BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7739196)

  • 1. [Larger sclerotomies for use of the multiport illumination system do not increase the complication risk of vitrectomy].
    Böker T; Augustin AJ; Schmidt H; Koch F
    Klin Monbl Augenheilkd; 1995 Feb; 206(2):78-82. PubMed ID: 7739196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention.
    Shimada H; Nakashizuka H; Hattori T; Mori R; Mizutani Y; Yuzawa M
    Ophthalmology; 2008 Dec; 115(12):2215-20. PubMed ID: 18930557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple technique to fixate the bullet pipe and perform bimanual vitreous surgery.
    Schmidt JC; Rodrigues EB; Meyer CH
    Indian J Ophthalmol; 2004 Dec; 52(4):337-8. PubMed ID: 15693332
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should associated intraoperative and/or postoperative photocoagulation be systematic during or after vitrectomy for proliferative diabetic vitreoretinopathy?].
    Hajji Z; Rouillot JS; Roth P; Grange JD
    J Fr Ophtalmol; 2003 Jan; 26(1):47-53. PubMed ID: 12610409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Air endotamponade in 52 vitrectomies due to proliferative diabetic retinopathy--retrospective comparison with 40 vitrectomies without endotamponade].
    Schulze S; Schulze S; Schmidt J; Kroll P
    Klin Monbl Augenheilkd; 2000 Dec; 217(6):329-33. PubMed ID: 11210705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior-segment surgeries with a two-port modified multiport illumination system.
    Er H; Firat P
    Ophthalmologica; 2008; 222(3):145-8. PubMed ID: 18497521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy.
    Woo SJ; Park KH; Hwang JM; Kim JH; Yu YS; Chung H
    Retina; 2009 Apr; 29(4):456-63. PubMed ID: 19174725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
    Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
    Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimanual vitreous surgery with slit-beam illumination and a multicoated contact lens.
    Kadonosono K; Kamezawa H; Uchio E; Tamaki Y; Araie M
    Retina; 2006; 26(6):708-9. PubMed ID: 16829821
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
    Hoerle S; Poestgens H; Schmidt J; Kroll P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):197-201. PubMed ID: 11935276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
    Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
    Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The predictive value of a classification for proliferative diabetic vitreoretinopathy].
    Hesse L; Heller G; Kraushaar N; Wesp A; Schroeder B; Kroll P
    Klin Monbl Augenheilkd; 2002; 219(1-2):46-9. PubMed ID: 11932810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phacoemulsification, vitrectomy and the implantation of an intraocular lens in diabetic patients.
    Vatavuk Z; Bencić G; Loncar VL; Petric I; Mandić Z
    Coll Antropol; 2005; 29 Suppl 1():13-6. PubMed ID: 16193668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitrectomy in proliferative diabetic retinopathy. Preoperative factors for surgical procedure and postoperative results].
    Ulbig M; Kampik A; Heidenkummer HP
    Fortschr Ophthalmol; 1990; 87(5):443-8. PubMed ID: 2272571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitrectomy in diabetic retinopathy: outcome, risk factors, complications].
    Helbig H; Kellner U; Bornfeld N; Foerster MH
    Klin Monbl Augenheilkd; 1998 May; 212(5):339-42. PubMed ID: 9677573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vitrectomy for diabetic retinopathy.
    Arrigg PG; Cavallerano J
    J Am Optom Assoc; 1998 Nov; 69(11):733-40. PubMed ID: 9844325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients].
    Körner F; Böhnke M
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):239-45. PubMed ID: 7791283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Self-sealing, sutureless sclerotomy in pars plana vitrectomy].
    Schmidt J; Nietgen GW; Brieden S
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):247-51. PubMed ID: 10572888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25-Gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity.
    Gonzales CR; Boshra J; Schwartz SD
    Retina; 2006 Sep; 26(7 Suppl):S42-6. PubMed ID: 16946678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.